| FGF2 |
Activated point mutants of FGFR2 |
reactome |
17 |
137 |
| FGF2 |
Angiopoietin receptor Tie2-mediated signaling |
pid |
50 |
441 |
| FGF2 |
Constitutive Signaling by Aberrant PI3K in Cancer |
reactome |
61 |
1618 |
| FGF2 |
Downstream signaling of activated FGFR1 |
reactome |
18 |
152 |
| FGF2 |
FGF signaling pathway ( FGF signaling pathway ) |
inoh |
44 |
749 |
| FGF2 |
FGFR1b ligand binding and activation |
reactome |
6 |
15 |
| FGF2 |
FGFR1c ligand binding and activation |
reactome |
12 |
67 |
| FGF2 |
FGFR2b ligand binding and activation |
reactome |
10 |
42 |
| FGF2 |
FGFR2c ligand binding and activation |
reactome |
13 |
79 |
| FGF2 |
FGFR3 mutant receptor activation |
reactome |
12 |
67 |
| FGF2 |
FGFR3c ligand binding and activation |
reactome |
13 |
68 |
| FGF2 |
FGFR4 ligand binding and activation |
reactome |
13 |
79 |
| FGF2 |
FGFRL1 modulation of FGFR1 signaling |
reactome |
13 |
58 |
| FGF2 |
FRS-mediated FGFR1 signaling |
reactome |
23 |
253 |
| FGF2 |
FRS-mediated FGFR2 signaling |
reactome |
25 |
300 |
| FGF2 |
FRS-mediated FGFR3 signaling |
reactome |
20 |
190 |
| FGF2 |
FRS-mediated FGFR4 signaling |
reactome |
22 |
231 |
| FGF2 |
Glypican 1 network |
pid |
26 |
96 |
| FGF2 |
Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) ) |
inoh |
228 |
7579 |
| FGF2 |
Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) ) |
inoh |
239 |
7722 |
| FGF2 |
Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) ) |
inoh |
237 |
7569 |
| FGF2 |
Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) ) |
inoh |
227 |
7534 |
| FGF2 |
Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) ) |
inoh |
228 |
7579 |
| FGF2 |
Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) ) |
inoh |
227 |
7534 |
| FGF2 |
Integrins in angiogenesis |
pid |
66 |
791 |
| FGF2 |
Negative regulation of FGFR1 signaling |
reactome |
26 |
303 |
| FGF2 |
Negative regulation of FGFR2 signaling |
reactome |
27 |
343 |
| FGF2 |
Negative regulation of FGFR3 signaling |
reactome |
22 |
219 |
| FGF2 |
Negative regulation of FGFR4 signaling |
reactome |
24 |
268 |
| FGF2 |
Non-integrin membrane-ECM interactions |
reactome |
23 |
97 |
| FGF2 |
Phospholipase C-mediated cascade: FGFR1 |
reactome |
16 |
122 |
| FGF2 |
Phospholipase C-mediated cascade; FGFR2 |
reactome |
18 |
155 |
| FGF2 |
Phospholipase C-mediated cascade; FGFR3 |
reactome |
13 |
80 |
| FGF2 |
Phospholipase C-mediated cascade; FGFR4 |
reactome |
15 |
107 |
| FGF2 |
PI-3K cascade:FGFR1 |
reactome |
21 |
211 |
| FGF2 |
PI-3K cascade:FGFR2 |
reactome |
23 |
254 |
| FGF2 |
PI-3K cascade:FGFR3 |
reactome |
18 |
154 |
| FGF2 |
PI-3K cascade:FGFR4 |
reactome |
20 |
191 |
| FGF2 |
PI3K Cascade |
reactome |
36 |
540 |
| FGF2 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling |
reactome |
83 |
2429 |
| FGF2 |
PIP3 activates AKT signaling |
reactome |
81 |
2003 |
| FGF2 |
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation |
reactome |
13 |
36 |
| FGF2 |
RAF/MAP kinase cascade |
reactome |
116 |
2212 |
| FGF2 |
SHC-mediated cascade:FGFR1 |
reactome |
21 |
211 |
| FGF2 |
SHC-mediated cascade:FGFR2 |
reactome |
26 |
324 |
| FGF2 |
SHC-mediated cascade:FGFR3 |
reactome |
18 |
154 |
| FGF2 |
SHC-mediated cascade:FGFR4 |
reactome |
23 |
252 |
| FGF2 |
Signaling by activated point mutants of FGFR1 |
reactome |
11 |
56 |
| FGF2 |
Signaling by activated point mutants of FGFR3 |
reactome |
12 |
67 |
| FGF2 |
Signaling by FGFR1 in disease |
reactome |
33 |
439 |
| FGF2 |
Signaling by FGFR2 IIIa TM |
reactome |
19 |
127 |
| FGF2 |
Signaling by FGFR2 in disease |
reactome |
27 |
353 |
| FGF2 |
Signaling by FGFR3 point mutants in cancer |
reactome |
22 |
233 |
| FGF2 |
Syndecan-4-mediated signaling events |
pid |
32 |
117 |
| FGF2 |
Syndecan interactions |
reactome |
20 |
127 |
| FGF2 |
MAPK signaling pathway |
kegg |
264 |
4851 |
| FGF2 |
Regulation of actin cytoskeleton |
kegg |
210 |
4425 |
| FGF2 |
Pathways in cancer |
kegg |
321 |
8293 |
| FGF2 |
Melanoma |
kegg |
69 |
1192 |
| FGF2 |
Hs_Endochondral_Ossification_WP474_87977 |
wikipathways |
43 |
117 |
| FGF2 |
Hs_Angiogenesis_WP1539_88983 |
wikipathways |
17 |
66 |
| FGF2 |
Hs_Cardiac_Hypertrophic_Response_WP2795_85087 |
wikipathways |
23 |
82 |
| FGF2 |
Hs_Lung_fibrosis_WP3624_91475 |
wikipathways |
23 |
45 |